Company Directory / pharmaceuticals
PrivateFor profitpharmaceuticalsDijon, France
Exeliom
Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs.
- Founded
- 2016 10 years ago
- Staff
- 1-10 band, as listed
- Followers
- - on LinkedIn
- Funding
- $22M as listed, currency not stated
Set against six million companies
Size
1-10 people: larger than 0% of companies with a size listed
Age
10 years old.
Reach
Website ranked #12,236,446 in the world for traffic, about 120 visits a month.
What it does
BiopharmaBiotechnologyHealth CarePharmaceutical
Funding, as listed
$22M currency not stated
- Rounds5
- LatestSeries a, Jun 2023
- Investors10, 4 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Exeliom, field by field. Contact details are held but never shown.
The company
- Name
- Exeliom
- Type
- For profit
- Status
- Private
- Founded
- 2016
- Founders
- Benjamin Hadida, Harry Sokol, Patrick Gervais, Philippe Langella
- Industry
- pharmaceuticals
- Categories
- Biopharma, Biotechnology, Health Care, Pharmaceutical
Where
- City
- Dijon
- Country
- France
- Markets
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 1-10
- Web traffic rank
- #12,236,446
- Monthly web visits
- 120
Funding, as listed
- Total
- 22,300,000 (currency not stated)
- Rounds
- 5
- Latest round
- Series a
- Latest round date
- Jun 2023
- Investors
- 10
- Lead investors
- 4
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Exeliom may be growing as it is focusing on expanding its product pipeline within the biopharmaceutical industry by targeting the gastric cancer landscape with a new immune modulating drug. This initiative indicates an active development phase and potential for market expansion. The company's engagement in the health care sector, specifically in addressing cancer treatment, suggests a strategic move to address a critical area of unmet medical need, which could lead to increased demand for their products.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
pharmaceuticals in France.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 88,142 companies in France and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.